Revised forecast
Second quarter (interim period) of the fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 6 August 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue, business profit and interim profit attributable to owners of the parent are expected to exceed the previously announced forecasts, due to steady performance across the businesses, led by the Functional Chemicals business, as well as improvements in non-recurring items and other factors.
| Item | Details |
|---|---|
| Net Sales | ¥1,390,000 million → ¥1,399,700 million（+0.7%） |
| Profit attributable to owners of the parent | ¥45,000 million (interim profit attributable to owners of the parent) → ¥69,100 million (interim profit attributable to owners of the parent)（+53.6%） |
| Net income per share | 30.90 Yen and sen (basic interim earnings per share) → 47.45 Yen and sen (basic interim earnings per share) |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 6 August 2026 |
| Previous-period results | Revenue ¥1,234,310 million, business profit ¥67,883 million, interim profit attributable to owners of the parent ¥36,935 million, basic interim earnings per share ¥24.23 |
| Reason for the revision | Revenue, business profit and interim profit attributable to owners of the parent are expected to exceed the previously announced forecasts, due to steady performance across the businesses, led by the Functional Chemicals business, as well as improvements in non-recurring items and other factors. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to steady performance across the businesses, led by the Functional Chemicals business, non-recurring items and other factors improved.